{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:18:56Z","timestamp":1787797136017,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vaccine.2026.129043","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:16:56Z","timestamp":1786796216000},"page":"129043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between post-vaccination adverse events and subsequent COVID-19 booster uptake in the Netherlands"],"prefix":"10.1016","volume":"90","author":[{"given":"Anne J.","family":"Huiberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud M.J.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina E.","family":"Hoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"van den Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129043_bb0005","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.129043_bb0010","author":"EMA"},{"key":"10.1016\/j.vaccine.2026.129043_bb0015","unstructured":"RIVM. COVID-19 vaccinatie Available from: https:\/\/lci.rivm.nl\/richtlijnen\/covid-19-vaccinatie#10--bijwerkingen-en-postvaccinale-verschijnselen accessed 14\u201304 2025."},{"key":"10.1016\/j.vaccine.2026.129043_bb0020","article-title":"Short-term side effects of COVID-19 vaccines (Astrazeneca, sputnik-V, and Sinopharm) in health care workers: a cross-sectional study in Iran","volume":"36","author":"Azimi-Nezhad","year":"2022","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.vaccine.2026.129043_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.876336","article-title":"Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study","volume":"10","author":"Ganesan","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129043_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1071","article-title":"Frequency of COVID-19 vaccine side effects and its associated factors among the vaccinated population of Pakistan: a cross-sectional study","volume":"6","author":"Yasmin","year":"2023","journal-title":"Health Sci Rep"},{"issue":"42","key":"10.1016\/j.vaccine.2026.129043_bb0035","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1016\/j.vaccine.2023.08.080","article-title":"Understanding low COVID-19 booster uptake among US adults","volume":"41","author":"Jacobs","year":"2023","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129043_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jiph.2023.01.020","article-title":"Implications for COVID-19 vaccine uptake: a systematic review","volume":"16","author":"Adu","year":"2023","journal-title":"J Infect Public Health"},{"issue":"17","key":"10.1016\/j.vaccine.2026.129043_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm9825","article-title":"COVID-19 vaccine hesitancy in eight European countries: prevalence, determinants, and heterogeneity","volume":"8","author":"Steinert","year":"2022","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129043_bb0050","first-page":"344","article-title":"COVID-19 vaccine hesitancy and early adverse events reported in a cohort of 7,881 Italian physicians","volume":"34","author":"Monami","year":"2022","journal-title":"Ann Ig"},{"key":"10.1016\/j.vaccine.2026.129043_bb0055","series-title":"Vaccinatiegraad COVID-19 vaccinatie Nederland, 2022","author":"Lanooij","year":"2024"},{"key":"10.1016\/j.vaccine.2026.129043_bb0060","unstructured":"RIVM. Ruim 2,5 miljoen coronaprikken gezet in de najaarsronde van 2024 2024 [Available from: https:\/\/www.rivm.nl\/nieuws\/ruim-25-miljoen-coronaprikken-gezet-in-najaarsronde-van-2024 accessed 28\u201304 2025."},{"key":"10.1016\/j.vaccine.2026.129043_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127561","article-title":"Determinants for not keeping up to date with COVID-19 vaccination in the 2023 vaccination round among medical risk groups, the Netherlands","volume":"62","author":"Osm\u00ebnaj","year":"2025","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129043_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085388","article-title":"Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - the VAccine study COVID-19 (VASCO)","volume":"14","author":"Huiberts","year":"2024","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129043_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.vaccine.2023.12.027","article-title":"Factors associated with COVID-19 autumn 2022 booster uptake in the Netherlands among older adults aged \u2265 60 years and younger adults with chronic conditions","volume":"42","author":"van Roekel","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129043_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12889-025-21691-x","article-title":"Uptake and hesitancy of the second booster dose of COVID-19 vaccine among the general population in China after the surge period of the COVID-19 pandemic: a large-scale national study","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129043_bb0085","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/vaccines10081229","article-title":"COVID-19 vaccination in China: adverse effects and its impact on health care working decisions on booster dose","volume":"10","author":"Luo","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129043_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1033473","article-title":"Uptake of COVID-19 booster shot among healthcare workers: a mediation analysis approach","volume":"10","author":"Rehman","year":"2022","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129043_bb0095","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1473-3099(22)00146-3","article-title":"COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID study","volume":"22","author":"Menni","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129043_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10071115","article-title":"Risk factors and incidence rates of self-reported short-term adverse events of COVID-19 vaccine booster dose","volume":"10","author":"Chen","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129043_bb0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/IJGM.S400458","article-title":"Adverse reactions of COVID-19 vaccines: a scoping review of observational studies","volume":"16","author":"Dhamanti","year":"2023","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.vaccine.2026.129043_bb0110","series-title":"Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Janssen COVID-19 Vaccine","author":"CDC","year":"2021"},{"key":"10.1016\/j.vaccine.2026.129043_bb0115","article-title":"Assessing the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults: a cross-sectional study","volume":"37","author":"Klib","year":"2024","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.vaccine.2026.129043_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129043_bb0125","article-title":"COVID-19 hospitalizations in the Netherlands, 2023\u20132024: disease burden and vaccine effectiveness","author":"de Gier","year":"2026","journal-title":"medRxiv"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:09:08Z","timestamp":1787796548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0264410X26008522"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between post-vaccination adverse events and subsequent COVID-19 booster uptake in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129043"}}